Metabolic stress and cancer: Is autophagy the common denominator and a feasible target?

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 5, 2014, Pages 597-614

  Giuliani, Charlett M ^a   Dass, Crispin R ^b  

^a VICTORIA UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

AMPK; ATP; autophagy; cancer; ROS

Indexed keywords

AUTOPHAGY; HUMAN; METABOLISM; NEOPLASMS; PHYSIOLOGICAL STRESS;

AUTOPHAGY; HUMANS; NEOPLASMS; STRESS, PHYSIOLOGICAL;

EID: 84898803580     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12191     Document Type: Review

References (76)

1. Kroemer GG, et al. Autophagy and the integrated stress response. Mol Cell 2010; 40: 280-293.
2. Omar HA, et al. Energy restriction as an antitumor target. Future Oncol 2010; 6: 1675-1679.
3. Moreno-Sanchez R, et al. Energy metabolism in tumor cells. FEBS J 2007; 274: 1393-1418.
4. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
5. Vander Heiden MG,. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 2011; 10: 671-684.
6. Filomeni G, et al. Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 2010; 6: 202-216.
7. Moruno-Manchon JF, et al. Glucose induces autophagy under starvation conditions by a p38 MAPK-dependent pathway. Biochem J 2013; 449: 497-506.
8. Kawaguchi T, et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. Cardiovasc Res 2012; 96: 456-465.
9. Sano R, et al. Endoplasmic reticulum protein BI-1 regulates Ca(2)(+)-mediated bioenergetics to promote autophagy. Genes Dev 2012; 26: 1041-1054.
10. Parys JB, et al. Role of the inositol 1,4,5-trisphosphate receptor/Ca2+-release channel in autophagy. Cell Commun Signal 2012; 10: 17-21.
11. Chang NC, et al. Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J 2010; 29: 606-618.
12. Williams T, et al. Basal autophagy induction without AMP-activated protein kinase under low glucose conditions. Autophagy 2009; 5: 1155-1165.
13. Morselli E, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis 2010; 1: e10.
14. Lee IH, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A 2008; 105: 3374-3379.
15. Lan F, et al. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008; 283: 27628-27635.
16. Ma L, et al. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells. PLoS ONE 2012; 7: e46055.
17. Wei Y, et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30: 678-688.
18. Pattingre S, et al. Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J Biol Chem 2009; 284: 2719-2728.
19. Wang X, et al. ER stress modulates cellular metabolism. Biochem J 2011; 435: 285-296.
20. Xi H, et al. Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKbeta leading to autophagy. Biochem Pharmacol 2013; 67: 899-910.
21. Chen H, et al. CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival. PLoS ONE 2013; 8: e56878.
22. Di Bartolomeo S, et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol 2010; 191: 155-168.
23. Vasseur S, et al. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci U S A 2009; 106: 1111-1116.
24. Rambold AS, Lippincott-Schwartz J,. Mechanisms of mitochondria and autophagy crosstalk. Cell Cycle 2011; 10: 4032-4038.
25. Kume S, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 2010; 120: 1043-1055.
26. Cheng KW, et al. Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress. EMBO Mol Med 2012; 4: 125-141.
27. Formentini L, et al. Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure. J Biol Chem 2009; 284: 17668-17676.
28. Ruderman NB, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010; 298: E751-E760.
29. Hoyer-Hansen M, et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell 2007; 25: 193-205.
30. Yin L, et al. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol 2009; 34: 1691-1699.
31. Oakhill JS, et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011; 332: 1433-1435.
32. Jones RG, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283-293.
33. Guo L, et al. Autophagy in premature senescent cells is activated via AMPK pathway. Int J Mol Sci 2012; 13: 3563-3582.
34. Guertin DA, Sabatini DM,. The pharmacology of mTOR inhibition. Sci Signal 2009; 2: e24.
35. Alexander A, et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 2010; 107: 4153-4158.
36. Hailey DW, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010; 141: 656-667.
37. Perez J, et al. Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model. PLoS ONE 2012; 7: e32458.
38. Gao M, et al. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res 2008; 68: 9348-9357.
39. Herrero-Martin G, et al. TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 2009; 28: 677-685.
40. Martinez-Outschoorn UE, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010; 9: 3256-3276.
41. Concannon CG, et al. AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J Cell Biol 2010; 189: 83-94.
42. Marino ML, et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010; 1: e87.
43. Son YO, et al. Cadmium induces autophagy through ROS-dependent activation of the LKB1-AMPK signaling in skin epidermal cells. Toxicol Appl Pharmacol 2011; 255: 287-296.
44. Martinez-Outschoorn UE, et al. Energy transfer in 'parasitic' cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle 2011; 10: 4208-4216.
45. Guo JY, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25: 460-470.
46. Hahn-Windgassen A, et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005; 280: 32081-32089.
47. Zhong D, et al. 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther 2008; 7: 809-817.
48. Xi H, et al. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol 2011; 67: 899-910.
49. Liu YQ, et al. Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells. PLoS ONE 2012; 7: e47049.
50. Chen Y, et al. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 2008; 15: 171-182.
51. Tang D, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190 (5): 881-892.
52. Tang D, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29: 5299-5310.
53. Chen Y, et al. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 2009; 16: 1040-1052.
54. Xu YN, et al. Mitochondrial dysfunction influences apoptosis and autophagy in porcine parthenotes developing in vitro. J Reprod Dev 2011; 57: 143-150.
55. Shirakawa T, et al. Production of free methylarginines via the proteasome and autophagy pathways in cultured cells. Mol Med Rep 2011; 4: 615-620.
56. Sarkar S, et al. Complex inhibitory effects of nitric oxide on autophagy. Mol Cell 2011; 43: 19-32.
57. Haldar SM, Stamler JS,. S-Nitrosylation at the interface of autophagy and disease. Mol Cell 2011; 43: 1-3.
58. Azad N, et al. Nitric oxide-mediated bcl-2 stabilization potentiates malignant transformation of human lung epithelial cells. Am J Respir Cell Mol Biol 2010; 42: 578-585.
59. Chanvorachote P, et al. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res 2006; 66: 6353-6360.
60. Azad N, et al. S-nitrosylation of Bcl-2 inhibits its ubiquitin- proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J Biol Chem 2006; 281: 34124-34134.
61. Alers S, et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32: 2-11.
62. Xiao B, et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011; 472: 230-233.
63. Fay JR, et al. Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev Res(Phila) 2009; 2: 301-309.
64. Cardaci S, et al. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci 2012; 125: 2115-2125.
65. Lee JW, et al. The association of AMPK with ULK1 regulates autophagy. PLoS ONE 2010; 5: e15394.
66. Hardie DG,. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8: 774-785.
67. Ethier C, et al. PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. PLoS ONE 2012; 7: e47978.
68. Daniel F, et al. Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells. World J Gastroenterol 2006; 12: 2895-2900.
69. Munoz-Gamez JA, et al. PARP-1 is involved in autophagy induced by DNA damage. Autophagy 2009; 5: 61-74.
70. Bai P, et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 2011; 13: 450-460.
71. Bai P, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 2011; 13: 461-468.
72. Zhao Y, Sun Y,. Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application. Neoplasia 2012; 14: 360-367.
73. Carrera AC,. TOR signaling in mammals. J Cell Sci 2004; 117: 4615-4616.
74. Fong MY, et al. Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS ONE 2012; 7: e42265.
75. Vemulapalli S, et al. The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas. Target Oncol 2011; 6: 29-39.
76. Choo AY, et al. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 2008; 105: 17414-17419.